Develops drugs for rare genetic diseases.
Dec 2025Revenue $376M/yrExpenses $350M/yr
No trend
Figures by year
Is Pharming Group profitable?
Yes. In the 12 months to Dec 2025, revenue was $376M and expenses $350M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $376M | $350M | $25.8M |
| Dec 2024 | $297M | $306M | −$8.62M |
| Dec 2023 | $245M | $251M | −$5.39M |
| Dec 2022 | $206M | $187M | $18.2M |
| Dec 2021 | $199M | $185M | $13.6M |
| Dec 2020 | $212M | $136M | $76.3M |
| Dec 2019 | $189M | $121M | $68.2M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.